Call for Proposals
Proposals due Wednesday, July 31, 2013 at 5:00 p.m. Eastern Time.
Acral melanoma, which occurs on the palms of the hands, soles of the feet, and under the nails, accounts for a small number of melanoma cases but has a survival rate of 10-20% lower than for cutaneous melanomas overall. Recognition that acral melanomas have a distinct genetic profile may account for the difference in survival. Yet, aside from the identification of cKIT alterations in 15-20% of acral melanomas, little is known about other molecular drivers of the disease.
The Melanoma Research Alliance (MRA) is proud to partner with the Hidary Foundation to offer a Team Science Award tocomprehensively characterize acral melanoma patient samples via state-of-the-art genomic technologies and other analytical approaches in the context of cutting edge biology for new points of therapeutic intervention. Multidisciplinary teams of two or more Principal Investigators (PIs) will receive up to $750,000 USD total over 2 years. There will be only one Award made under this mechanism.